Prolonged Neutropenia After Neoadjuvant Radiation Therapy and Chemotherapy Using Oxaliplatin and Capecitabine for Rectal Cancer

Similar Items

• RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanced Rectal Cancer
  od: Wong, Stuart J., i dr.
  Izdano: (2011)
• Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer
  od: Wong, Stuart J., i dr.
  Izdano: (2014)
• Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma
  od: Jia, Angela Y., i dr.
  Izdano: (2019)
• Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
  od: Zhang, Qibo, i dr.
  Izdano: (2021)
• Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
  od: Allegra, Carmen J., i dr.
  Izdano: (2015)